0000899243-19-004257.txt : 20190220
0000899243-19-004257.hdr.sgml : 20190220
20190220163024
ACCESSION NUMBER: 0000899243-19-004257
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190215
FILED AS OF DATE: 20190220
DATE AS OF CHANGE: 20190220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Jason S.
CENTRAL INDEX KEY: 0001713925
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 19618684
MAIL ADDRESS:
STREET 1: 9301 AMBERGLEN BOULEVARD, SUITE 100
STREET 2: C/O MOLECULAR TEMPLATES, INC.
CITY: AUSTIN
STATE: TX
ZIP: 78729
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Molecular Templates, Inc.
CENTRAL INDEX KEY: 0001183765
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943409596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
BUSINESS PHONE: 512 896 1555
MAIL ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
FORMER COMPANY:
FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020828
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-02-15
0
0001183765
Molecular Templates, Inc.
MTEM
0001713925
Kim Jason S.
C/O MOLECULAR TEMPLATES, INC.
9301 AMBERGLEN BLVD., SUITE 100
AUSTIN
TX
78729
0
1
0
0
See Remarks
Stock Option (right to buy)
4.66
2019-02-15
4
A
0
130000
0.00
A
2029-02-15
Common Stock
130000
130000
D
25% of the shares subject to the option shall vest on February 15, 2020, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months.
President and Chief Operating Officer
/s/ Matthew J. Gardella, Attorney-in-Fact
2019-02-20